Effect of Chinese medicine compound on intestinal bifidobacteria recovery and CD4+ T-Cell activation in postoperative chemotherapy patients with breast cancer .

In 30 seconds

This randomized controlled trial investigated the effects of a traditional Chinese medicine compound on intestinal bifidobacteria recovery and CD4+ T-cell activation in breast cancer patients undergoing postoperative chemotherapy. The observation group exhibited significant increases in bifidobacteria to 9.01±1.49 lg (CFU/g) and CD4+ T-cell counts to 969/μL, indicating enhanced immune function and gut microbiota balance.

Key findings

• Bifidobacteria levels increased to 9.01±1.49 lg (CFU/g) in the observation group.
• CD4+ T-cell counts reached 969/μL in the observation group.
• The observation group had significantly lower adverse reaction rates (P-values: 0.002, 0.006, 0.030).
• Better control of gastrointestinal conditions and disease progression was observed (P<0.001).

Why it matters

The study highlights the potential of traditional Chinese medicine as an adjunctive therapy to improve gut health and immune response in breast cancer patients undergoing chemotherapy, which may enhance overall treatment outcomes.